IRMD: IRADIMED Company Sales Revenue

IRADIMED CORPORATION (IRMD) maintains stable sales volumes due to minimal geopolitical impact, attributed to the humanitarian status of its products. The value of 0.09 describes the current status of the metric, which is based on flawless resource administration and R&D transparency. Growth is underpinned by a monopoly status in the MRI-compatible pump segment, granting IRADIMED CORPORATION (IRMD) the pricing power to independently determine the cost of equipment and consumables.

Revenue and Sales Volume: IRADIMED (IRMD) for 07/04/2022 - 11/13/2026

Comprehensive metric breakdowns and analytics for IRADIMED (IRMD)

- current price and projected stock value:

Share Price IRADIMED Inc.|IRMD - Consensus Target

- market capitalization information:

Market Value IRADIMED CORPORATION|IRMD - Total Company Value

- balance sheet net asset value indicators:

Accounting Value per Share IRADIMED|IRMD - Book Capitalization|Market-to-Book Ratio iradimed.com|IRMD - Company Total Assets

- company liabilities and liquidity data:

- company profitability and valuation multiples indicators:

IRMD - Net Income|Expected Net Income IRADIMED CORPORATION|IRMD - P/E Multiple|Projected Price to Earnings Ratio iradimed.com|IRMD - Price/Earnings to Growth Ratio|Enterprise Value to EBITDA Multiple IRADIMED CORPORATION|IRMD - Operating profit before deduction of amortization|Net earnings per share (EPS TTM) IRADIMED|IRMD - Net earnings per share (EPS TTM)|Year-over-year net earnings per share change for the last twelve months iradimed.com|IRMD - Earnings per share growth in current year|Net earnings per share change forecast for next year IRADIMED CORPORATION

- company sales and revenue statistics:

IRMD - Company Revenue|Company Future Sales Volume IRADIMED Inc.|IRMD - P/S Multiple|Market Cap to Future Revenue Ratio IRADIMED CORPORATION

Summary company analysis:IRMD IRADIMED Inc.

This indicator consolidates daily revenue data, eliminating reporting gaps to ensure an accurate analysis of operational scale. The metric measures real consumer demand, allowing investors to assess the effectiveness of the commercial strategy. For IRADIMED CORPORATION (IRMD), the stability of the company's actual sales is supported by the healthcare sector's independence from GDP fluctuations. Demand for monitoring systems is driven by industry healthcare standards. The actual sales dynamics of IRADIMED CORPORATION (IRMD) reflect the resilience of long-term hospital equipment replacement cycles.

Key competitors